Mixed S-nitrosylated polymerized bovine hemoglobin species moderate hemodynamic effects in acutely hypoxic rats

American Journal of Respiratory Cell and Molecular Biology

Volumn 42, Issue 2, 2010, Pages 200-209

  Irwin, David ^a   Buehler, Paul W ^b   Alayash, Abdu I ^b   Jia, Yiping ^b   Bonventura, Joe ^c,d   Foreman, Ben ^a   White, Molly ^a   Jacobs, Robert ^e   Piteo, Brian ^e   TissotvanPatot, Martha C ^a   Hamilton, Karyn L ^e   Gotshall, Robert W ^e  

^a UNIVERSITY OF COLORADO   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MARINE LABORATORY   (United States)

^e Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Blood pressure; Cardiac output; Hemoglobin based oxygen carrier; Oxygen delivery; S nitrosylation

Indexed keywords

HEMOGLOBIN; NITRIC OXIDE; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART OUTPUT; HEMODYNAMICS; HYPOXIA; INSPIRATORY CAPACITY; LUNG ARTERY PRESSURE; MALE; NITROSYLATION; NONHUMAN; OXYGEN TRANSPORT; OXYGENATION; RAT;

ACUTE DISEASE; ANIMALS; ANOXIA; BLOOD PRESSURE; BLOOD SUBSTITUTES; CARDIAC OUTPUT; CATTLE; HEMODYNAMICS; HEMOGLOBINS; MALE; NITRIC OXIDE DONORS; NITRITES; NITROSO COMPOUNDS; OXYGEN; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTION;

BOVINAE; RATTUS;

EID: 74549207960     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0364OC     Document Type: Article

References (37)

1. 2-affinity recombinant hemoglobin polymers in mouse. J Appl Physiol 2006; 100:1688-1691.
2. Ortegon DP, Davis MR, Sampson JB, Dick E, Kashyap V, Kerby J. Bovine hemoglobin-based oxygen-carrying solution (HBOC-201) improves flap survival in a rat model of epigastric flap failure. Microsurgery 2006;26:203-206.
3. Isaac G, Yi G-H, Schulman AR, Morrow BT, Cheng Y, Gu A, Zhang G, Oz MC, Burkhoff D, Wang J. A polymerized bovine hemoglobin oxygen carrier preserves regional myocardial function and reduces infarct size after acute myocardial ischemia. Am J Physiol Heart Circ Physiol 2006;291:H1126-H1137.
4. Bonegio RGB, Fuhro R, Ragno G, Valeri CR, Lieberthal W. A comparison of the acute hemodynamic and delayed effects of 50% exchange transfusion with two different cross-linked hemoglobin based oxygen carrying solutions and pentastarch. Artif Cells Blood Substit Immobil Biotechnol 2006;34:145-157.
5. Hess JR, MacDonald VW, Brinkley WW. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 1993;74:1769-1778.
6. Hess JR, MacDonald VW, Gomez C, Coppes V. Increased vascular resistance with hemoglobin-based oxygen carriers. Artif Cells Blood Substit Immobil Biotechnol 1994;22:361-372.
7. Tsai AG, Friesenecker B, Cabrales P, Hangai-Hoger N, Intaglietta M. The vascular wall as a regulator of tissue oxygenation. Curr Opin Nephrol Hypertens 2006;15:67-71.
8. Irwin DC, Foreman B, Morris K, White M, Sullivan T, Jacobs R, Monnet E, Hackett T, Tissotvanpatot MC, Hamilton KL, Gotshall RW. Polymerized bovine hemoglobin decreases oxygen delivery during normoxia and acute hypoxia in the rat. Am J Physiol Heart Circ Physiol 2008;295:H1090-H1099.
9. Alayash AI, D'Agnillo F, Buehler PW. First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives. Expert Opin Biol Ther 2007;7:665-675.
10. Buehler PW, Alayash AI. All hemoglobin-based oxygen carriers are not created equally. Biochim Biophys Acta 2008;1784:1378-1381.
11. Winslow RM. Current status of oxygen carriers ('blood substitutes'): 2006. Vox Sang 2006;91:102-110.
12. Yu B, Raher MJ, Volpato GP, Bloch KD, Ichinose F, Zapol WM. Inhaled nitric oxide enables artificial blood transfusion without hypertension. Circulation 2008;117:1982-1990.
13. Cabrales P, Tsai AG, Intaglietta M. Nitric oxide regulation of microvascular oxygen exchange during hypoxia and hyperoxia. J Appl Physiol 2006;100:1181-1187.
14. Moore EE, Johnson JL, Cheng AM, Masuno T, Banerjee A. Insights from the studies of blood substitutes in trauma. Shock 2005;24:197-205.
15. Alayash AI. Oxygen therapeutics: can we tame haemoglobin? Nat Rev Drug Discov 2004;3:152-159.
16. Tsai AG, Cabrales P, Manjula BN, Acharya SA, Winslow RM, Intaglietta M. Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers. Blood 2006;108:3603-3610.
17. Gotshall RW, Hamilton KL, Foreman B, Tissotvanpatot MC, Irwin DC. Hemoglobin-based oxygen carrier and phosphodiesterase-5 inhibition. Crit Care Med 2009;37:1988-1993.
18. Asanuma H, Nakai K, Sanada S, Minamino T, Takashima S, Ogita H, Fujita M, Hirata A, Wakeno M, Takahama H, et al. S-nitrosylated and PEGylated hemoglobin, a newly developed artificial oxygen carrier, exerts cardioprotection against ischemic hearts. J Mol Cell Cardiol 2007;42:924-930.
19. Buehler PW, Alayash AI. Oxygen sensing in the circulation: "cross talk" between red blood cells and the vasculature. Antiox Redox Signal 2004;6:1000-1010.
20. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996;380:221-226.
21. Ricardo KFS, Shishido SM, de Oliveira MG, Krieger MH. Characterization of the hypotensive effect of S-nitroso-N-acetylcysteine in normotensive and hypertensive conscious rats. Nitric Oxide 2002;7: 57-66.
22. Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, Gernert K, Piantadosi CA. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 1997;276:2034-2037.
23. Sonveaux P, Kaz AM, Snyder SA, Richardson RA, Cardenas-Navia LI, Braun RD, Pawloski JR, Tozer GM, Bonaventura J, McMahon TJ, Stamler JS, Dewhirst MW. Oxygen regulation of tumor perfusion by S-nitrosohemoglobin reveals a pressor activity of nitric oxide. Circ Res 2005;96:1119-1126.
24. Buehler PW, Boykins RA, Jia Y, Norris S, Freedberg DI, Alayash AI. Structual and functional characterization of glutaraldehyde-polymerized bovine hemoglobin and its isolated fractions. Anal Chem 2005;77: 3466-3478.
25. Boykins R, Buehler PW, Jia Y, Venable R, Alayash AI. O-raffinose crosslinked hemoglobin lacks site-specific chemistry in the central cavity: structural and functional consequences of beta93Cys modification. Proteins 2005;59:840-855.
26. Buehler PW, D'Agnillo F, Hoffman V, Alayash AI. Effects of endogenous ascorbate on oxidation, oxygenation and toxicokinetics of cellfree modified hemoglobin after exchange transfusion in rat and guinea pig. J Pharmacol Exp Ther 2007;323:49-60.
27. Herold S, Rock G. Reactions of deoxy-, oxy-, and methemoglobin with nitrogen monoxide: mechanistic studies of the S-nitrosothiol formation under different mixing conditioins. J Biol Chem 2003;278:6623-6634.
28. Alayash AI, Fratantoni JC, Bonaventura C, Bonaventura J, Cashon RE. Nitric oxide binding to human ferrihemoglobins cross-linked between either [alpha] or [beta] subunits. Arch Biochem Biophys 1993;303: 332-338.
29. Hayashi A, Suzuki M, Shin M. An enzymatic reduction system for memyoglobin and mehemoglobin, and its application to functional studies of oxygen cariers. Biochim Biophys Acta 1973;310:309-316.
30. Jia Y, Ramasamy S,Wood F, Alayash AI, Rifkind J. Cross-linking with Oraffinose lowers oxygen affinity and stabilizes haemoglobin in a noncooperative T-state conformation. Biochem J 2004;384:367-375.
31. Manly G, Hemphill J, Morabito D, Erickson V, Holcroft J, Derugin N. knudson N. Small-volume resuscitation with the hemoglobin substitutue HBOC-201: effect on brain tissue oxygenation. Adv Exp Med Biol 2003;530:311-317.
32. Patel M, Feinstein A, Saenz A, Majetschak M, Proctor K. Prehospital HBOC-201 after traumatic brain injury and hemorrhagic shock in swine. J Trauma 2006;61:46-56.
33. Rivera-Chvez F, Huerta S, Brown R, York G, Minei J. Resucitation from hemorrhagic shock comparing standard hemoglobin-based carrier (HBOC) 201 versus 7.5% hypertonic HBOC 201. J Trauma 2007;63:1113-1119.
34. Johnson T, Arnaud F, Dong F, Philbin N, Rice J, Asher L, Arrisueno M, Warndorf M, Gurney J, McGwin G, et al. Bovine polymerized hemoglobin (hemoglobin-based oxygen carrier-201) resuscitation in three swine models of hemorrhagic shock with militarily relevant delayed evacuation-effects on histopathology and organ function. Crit Care Med 2006;34:1464-1474.
35. Olson JS, Foley EW, Rogge C, Tsai A-L, Doyle MP, Lemon DD. NO scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic Biol Med 2004;36:685-697.
36. Deem S, Kim J-U, Manjula BN, Acharya AS, Kerr ME, Patel RP, Gladwin MT, Swenson ER. Effects of S-nitrosation and cross-linking of hemoglobin on hypoxic pulmonary vasoconstriction in isolated rat lungs. Circ Res 2002;91:626-632.
37. Deem S, Kim SS, Min J-H, Eveland R, Moulding J, Martyr S, Wang X, Swenson ER, Gladwin MT. Pulmonary vascular effects of red blood cells containing S-nitrosated hemoglobin. Am J Physiol Heart Circ Physiol 2004;287:H2561-H2568.